Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP7 | P09237 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | PLAU | P00749 | 1/20 | 0.37 |
| ▸ | PLAT | P00750 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8717107 | 0.90 | GAA (0.45) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL7334523 | 0.88 | GAA (0.42) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL8947835 | 0.88 | GAA (0.42) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL8716958 | 0.87 | CCKBR (0.45) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL8716864 | 0.86 | GAA (0.45) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL7326146 | 0.86 | GAA (0.45) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL7302360 | 0.83 | ACACB (0.45) | GAAF2ACACBPLGPLAU | |
| SCHEMBL7332989 | 0.83 | F2 (0.47) | F2ACACBPLGPLAT | |
| SCHEMBL8719933 | 0.82 | CCKBR (0.45) | GAAF2ALDH1A1MEN1KMT2A | |
| SCHEMBL7332615 | 0.82 | F2 (0.49) | F2PLGPLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0559046-B1 | N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors | HOFFMANN LA ROCHE (CH) | 2001-07-11 | — | — | EP | disclosed |
| EP-0559046-A1 | N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1993-09-08 | — | — | EP | disclosed |